NVO Hisse Senedi Fiyat Grafiği
NVO Kâr Dağıtımı
Novo Nordisk A/S
$46.4
0.71%
$0.32
Kapanışta: May 11, 16:00:00 GMT-4
$47.54
2.45%
$1.14
Ön Piyasa: May 12, 06:13:18 GMT-4
Geri
Novo Nordisk A/S (NVO) Kâr Dağıtımı
Önemli İstatistikler
Önceki Kapanış
$46.07
Açılış fiyatı
$46.69
Günün Aralığı
$46.27 - $47.79
52 haftalık aralık
$35.12 - $81.44
İşlem hacmi
17.7M
Ort.Hacim
20.1M
Dividend yield
--
EPS (TTM)
3.60
Piyasa Değeri
$210.8B
Novo Nordisk A/S nedir?
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
